Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
AstraZeneca
Colorcon
McKesson
Dow

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

See Plans and Pricing

« Back to Dashboard

Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-07-07
Court District Court, D. Delaware Date Terminated 2017-04-25
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ACCORD HEALTHCARE INC.; ACORDA THERAPEUTICS INC. ; ACTAVIS INC.; ACTAVIS LABORATORIES FL INC.; ACTAVIS PHARMA INC.; ALKEM LABORATORIES LTD.; ALKERMES PHARMA IRELAND LIMITED; ANDRX CORPORATION; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; MYLAN PHARMACEUTICALS INC.; ROXANE LABORATORIES INC.; TEVA PHARMACEUTICALS USA INC.; WATSON LABORATORIES INC.
Patents 5,540,938; 8,007,826; 8,354,437; 8,440,703; 8,663,685
Attorneys A. Taylor Corbitt; Aaron Stiefel; Alison L. Maddeford; Brie L.B. Buchanan; Bryce A. Cooper; Cedric C. Y. Tan; Charles B. Klein; Cindy Ahn; Daniel P. DiNapoli; David A. Bilson; Eve H. Ormerod; George C. Lombardi; George Chih-Lun Yu; George J. Barry , III; Grace Yang, Ph.D.; Imron T. Aly; Jack B. Blumenfeld; Jason Pesick; Jeffrey Martin; Jeremy A. Tigan; John C. Phillips , Jr.; Joseph R. Robinson; Karen L. Carroll; Mary Matterer; Maryellen Noreika; Megan C. Haney; Micheal L. Binns; Neal C. Belgam; Nicole R. Sullivan; Reid Smith; Robert L. Florence; Sailesh K. Patel; Samuel S. Park; Sharick Naqi; Soumitra Deka; Steven J. Fineman; Timothy H. Kratz; Yun Wei
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Smith, Katzenstein, & Jenkins LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Acorda Therapeutics Inc. v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-07 1 Actavis for patent infringement of United States Patent Nos. 8,007,826 (the “’826 patent”), 8,354,437…alleging that the ’826 patent, the ’437 patent, the ’703 patent, and the ’685 patent are “invalid, unenforceable…expiration of the ’826 patent, the ’437 patent, the ’703 patent and the ’685 patent.” Case 1:14-cV-00882…8,354,437 (the “’437 patent”), 8,440,703 (the “’703 patent”) and 8,663,685 (the “’685 patent”) (collectively,…for the ’826 patent as May 26, 2027, the ’437 patent as December 22, 2026, the ’703 patent as April 8, External link to document
2016-03-16 195 Orange Book-listed patents: U.S. Patent Nos. 5,540,938 (the '" 938 patent"), 8,007,826 (…quot; 703 patent"), and 8,663, 685 (the '" 685 patent"). The asserted patents relate … (the '" 826 patent"), 8,354,437 (the '"437 patent"), 8,440,703 (the '…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification External link to document
2016-09-01 254 infringement of United States Patent No. 5,540,938 (the “’938 patent”), United States Patent No. 8,007,826 (the…the “’826 patent”), United States Patent No. 8,354,437 (the “’437 patent”), United States Patent No. 8,…8,400,703 (the “’703 patent”), and United States Patent No. 8,663,685 (the “’685 patent”) (collectively …the ’437 patent; claims 36, 38, and 45 of the ’703 patent; and claims 3 and 5 of the ’685 patent (collectively…claims 3 and 8 of the ’938 patent; claims 1, 7, 38, and 39 of the ’826 patent; claims 1, 2, 5, 22, 32, External link to document
2016-09-30 262 II. PATENTS-IN-SUIT2 A. United States Patent No. 5,540,938 (the “’938 Patent”) … A. United States Patent No. 5,540,938 (the “’938 Patent”) .............................…the Acorda Patents. (JTX-0002 (’826 Patent); JTX-0003 (’437 Patent); JTX-0004 (’703 Patent); JTX-0005 …the Acorda Patents. (JTX-0002 (’826 Patent); JTX-0003 (’437 Patent); JTX-0004 (’703 Patent); JTX-0005…the ’938 Patent claims: 3, 8; the ’826 Patent claims: 1, 7, 38, 39; the ’437 Patent claims: External link to document
2016-09-30 263 TECHNICAL TERMS Elan Patent United States Patent No. 5,540,938 Acorda Patents United … ’938 patent” or the “Elan patent”) and United States Patent Nos. 8,007,826 (“the ’826 patent”), 8,354,437…Ex. 1, ¶¶ 10-41.) The ’826 patent, ’437 patent, ’703 patent, and ’685 patent are sometimes referred to…States Patent No. 8,440,703 United States Patent No. 8,663,685 Patents-in-Suit… Elan Patent and Acorda Patents, collectively Asserted Claims Claims of the patents-in-suit External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
McKesson
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.